Compare ACRV & UBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACRV | UBCP |
|---|---|---|
| Founded | 2018 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.0M | 80.3M |
| IPO Year | 2022 | 1995 |
| Metric | ACRV | UBCP |
|---|---|---|
| Price | $1.74 | $14.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 188.2K | 6.9K |
| Earning Date | 11-16-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 6.80% |
| EPS Growth | ★ 15.13 | 5.51 |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.21 |
| Revenue Next Year | N/A | $6.72 |
| P/E Ratio | ★ N/A | $20.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $12.65 |
| 52 Week High | $3.56 | $17.34 |
| Indicator | ACRV | UBCP |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 46.76 |
| Support Level | $1.63 | $13.31 |
| Resistance Level | $1.87 | $16.08 |
| Average True Range (ATR) | 0.11 | 0.51 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 30.00 | 50.00 |
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which include accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. The Company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are residential mortgage, commercial, and installment loans. The bank also operates in Marshall County, West Virginia.